Posted on January 19th, 2012 by
Renal dysfunction in patients being considered for implantation of a left ventricular assist device (LVAD) is largely reversible, according to the results of a recent retrospective single-center analysis. Glomerular filtration rate (GFR) increased from admission (53.2 ± 21.4 ml/min/1.73 m2) to 1 month after the left ventricular assist device was implanted (87.4 ± 27.9 ml/min/1.73 m2, P<0.0001). At three and six months, GFR remained significantly above what was seen prior to implantation (P< 0.0001), reported Sudhir S. Kushwaha, MD, and colleagues from the Mayo Clinic in Rochester, Minn
MedPage Today, by Kurt Ullman, 12/2011
You must be logged-in to the site to post a comment.